US2011136743A1PendingUtilityA1

Survivin, a protein that inhibits cellular apoptosis, and its modulation

Assignee: UNIV YALEPriority: Nov 20, 1996Filed: Oct 5, 2009Published: Jun 9, 2011
Est. expiryNov 20, 2016(expired)· nominal 20-yr term from priority
G01N 2510/00G01N 33/5008C07K 16/303A61K 48/00A61K 2039/505C07K 14/4747C07K 2317/73G01N 33/5011A61P 35/00G01N 33/5044C07K 16/3061C07K 16/3015G01N 33/5017C07K 16/3069G01N 33/68C07K 16/3046G01N 33/6893A61P 39/00C07K 16/3023A61K 38/00A61P 43/00G01N 33/57557A61K 39/00C12N 15/11
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides the amino acid of a protein that inhibits cellular apoptosis, herein termed the Survivin protein and nucleic acid molecules that encode Survivin. Based on this disclosure, the present invention provides isolated Survivin protein, isolated Survivin encoding nucleic acid molecules, methods of isolating other members of the Survivin family of proteins, methods for identifying agents that block Survivin mediated inhibition of cellular apoptosis, methods of using agents that block Survivin mediated inhibition or Survivin expression to modulate biological and pathological processes, and methods of assaying Survivin activity.

Claims

exact text as granted — not AI-modified
1 . A method of modulating apoptosis in a cell, comprising the step of adminstering to the cell an agent that modulates the amount or activity of Survivin in the cell. 
     
     
         2 - 3 . (canceled) 
     
     
         4 . A method of inhibiting apoptosis in a cell, comprising the step of administering to the cell a Survivin polypeptide, Survivin polypeptide fragment or an apoptosis-inhibiting peptidomimetic thereof in an amount effective to inhibit apoptosis in the cell. 
     
     
         5 . A method of inhibiting apoptosis in a cell, comprising the step of administering to the cell a transgene encoding a Survivin polypeptide or Survivin polypeptide fragment thereof, the transgene being effective to cause expression of the Survivin polypeptide or fragment thereof in an amount effective to inhibit apoptosis in the cell. 
     
     
         6 - 59 . (canceled)

Join the waitlist — get patent alerts

Track US2011136743A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.